By attending this well-recognised industry event you will be able to:

Benchmark your strategies for patent lifecycle extensions with your direct peers in leading pharma and biotech companies and gain advantage over your competitors.

The eminent speakers will share their best practice insights and offer clarity on the latest SPC court decisions and regulatory developments and the implications for your patent lifecycle management strategies.

In addition you will gain a full analysis of the complex issues and case law surrounding the intersection of competition law and IP, with a particular focus on reverse settlements, ‘abuse of dominance’, disclosure of prior art and patent pooling. You will receive direct guidance from the European Commission on lifecycle extensions and how to avoid anti-trust enforcement action.

Our outstanding speaker faculty includesexpert in-house counsel:

- Tony Rollins, Managing Counsel European Patents,Merck (UK)
- Jürgen Dressel, Head of Patent Litigation ex USA,Novartis (Switzerland)
- Brian Tempest, Chairman,Hale & Tempest (Ex CEO Ranbaxy)
- James Robertson, Senior Manager, Patent Counsel,GlaxoSmithKline (Belgium)
- Lars Sparre Conrad, Senior Patent Counsel, Corporate Patents & Trademarks,H. Lundbeck (Denmark)
- Dr. Deepak Murpani, Vice President, R&D (Formulation/Product development), Genepharm (Greece)
- Bernard McDonald, Global IP Manager, Legal Affairs Group,Emergent BioSolutions (UK)
Plushear directly from the regulator and patent offices about the latest case law decisions and their interpretations:

- Dieter Tzschoppe, Director Pure and Applied Organic Chemistry,European Patent Office
- Lavinia Teodorescu, DG Competition Antitrust Pharma and Health Services, European Commission
- Martijn de Lange,Netherlands Patent Office
- Dr Lawrence Cullen, Deputy Director (Biotechnology, Pharmaceuticals & Organic Chemistry) Patents Directorate,Intellectual Property Office (UK IPO)
And meet many more international IP expert speakers.

For more information, check the link below:

http://www.c5-online.com/files/pdf/marketing/509L12-LON-E.pdf

Tags: c5, pharma
No Comments »